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Abstract
Many suspected breast cancer risk factors, including the pesticide dichlorodiphenyltrichloroethane 
(DDT) and its metabolite dichlorodiphenyldichloroethylene (DDE), are stored in fat where they 
could influence carcinogenesis. We tested the hypothesis that the relationship of DDT and DDE 
(DDTs) with adiposity is modified by disposition to develop breast cancer. We predicted that 
concentrations of serum DDTs would be inversely correlated with body mass index (BMI) during 
active exposure when DDTs move into the larger fat pool. We described this correlation an average 
of 17 years before breast cancer was diagnosed, in a prospective nested case-control study in the 
Child Health and Development Studies. Women entered the study during pregnancy from 
1959-1966 when DDT was in active use. 133 breast cancer cases were diagnosed under age 50 as 
of 1998. Mean time to diagnosis was 17 years. 133 controls were matched to cases on birth year. 
We observed the expected inverse correlation of serum DDTs with BMI only in women who 
remained cancer-free and not in women who ultimately developed breast cancer (p for interaction 
<0.05). Findings suggest that vulnerability to breast cancer before age 50 may be associated with 
an uncoupling of the inverse correlation between BMI and serum DDTs. Investigation into 
mechanisms may eventually reveal early biomarkers of breast cancer risk.
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INTRODUCTION
Previous Research on DDT and Breast Cancer in the Child Health and Development 
Studies
The Child Health and Development Studies (CHDS) is a large pregnancy cohort that began 
in 1959 1-3 with long-term follow-up for cancer in two generations including fathers, 
mothers and their now-adult children.4-9 Commercial “DDT” 
(dichlorodiphenyltrichloroethane, p,p’-DDT) is a pesticide that was used heavily in the 
United States beginning in 1945, peaking in 1959 and finally banned in the U.S. in 1972.8, 10 
The compound p,p’-DDT is the highest concentration ingredient of commercial “DDT” and 
the component responsible for its insecticidal properties. (https://www.atsdr.cdc.gov/
toxprofiles/tp35-c4.pdf, accessed 5/17/18). In a previous prospective study in the CHDS we 
reported that p,p’-DDT assayed in early postpartum serum samples was associated with 
breast cancer diagnosed before age 50, an average of 17 years after blood collection. The 
p,p’-DDT association was strongest in birth cohorts that were initially exposed to DDT prior 
to age 14 (Odds Ratio = 5.4, 95 percent Confidence Interval=1.7,17.1, p-value for interaction 
with age at exposure=0.02 (see Table 4 in Cohn et al.).5
Lipophilic carcinogens, body fat function and breast cancer
In 2015, the International Agency for Research on Cancer classified DDT as ‘Probably 
carcinogenic in humans (Group 2A) citing sufficient evidence that DDT causes cancer in 
experimental animals and limited evidence in humans”.11 Both p,p’-DDT and its primary 
metabolite dichlorodiphenyldichloroethylene (p,p’-DDE) are lipophillic and are persistently 
stored in human adipose tissue, including in the breast.12, 13 It is notable that adipose tissue 
also surrounds breast epithelial cells, the primary cell type in which breast cancer develops, 
and has been implicated in extensive paracrine effects on breast carcinogenesis. We posit 
that the dual roles of adipose tissue in paracrine carcinogenesis and in storing lipophilic 
contaminants may not be independent, and that adipose tissue may also respond to lipophilic 
exposures in ways that are further permissive of carcinogenesis.14 Several lines of evidence 
support this notion. For example, DDTs have experimentally produced at least two key 
characteristics of carcinogens in adipose: inflammation (e.g. macrophage infiltration) and 
altered nutrient supply (e.g. perturbed nutrient processing and increased adipose mass).15-18 
Additionally, predisposition to mammary cancer appears to make mice more susceptible to 
adipose tissue abnormalities (e.g. increased adipose mass) that are viewed as mammary 
cancer risk factors.19 These observations raise the possibility that predisposition to breast 
cancer somehow influences adjacent adipose tissue function with respect to lipophilic 
chemical storage and carcinogenic processes; raising the possibility that adipose tissue 
function is an early marker for breast cancer risk.
Objective and Rationale for the Present Study.
As adipose tissue accumulates, given concentrations of DDTs are accumulated into a larger 
fat pool causing their dilution on a lipid basis. During active exposure to DDTs it is thus 
expected that DDTs would be sequestered in fat leading to an inverse correlation of serum 
and adipose levels of DDTs with body fat mass.20 We indirectly explore here whether 
predisposition to breast cancer alters adipose tissue properties in women who develop early 
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breast cancer. Thus we predicted that women who went on to develop breast cancer by age 
50 over an average follow-up of 17 years would not show the expected negative correlation 
of body mass index (BMI) with lipophilic DDTs at baseline.
CHDS blood samples were collected from 1959-1967, prior to the ban on DDT in the United 
States.8 Therefore the null hypothesis in the present study is that there would be an inverse 
correlation of body mass index (BMI) with serum p,p’-DDT and serum p,p’-DDE in all 
CHDS subjects at baseline, regardless of their future breast cancer status. The present study 
tests this hypothesis in an effort to help discover whether higher adipose levels of DDTs, 
beyond what is explained by toxicokinetics, are a possible mechanism for the DDT – breast 
cancer associations we have previously observed in the CHDS.
MATERIALS AND METHODS
Design
In this prospective, nested case-control study we investigated correlations of serum DDT 
compounds with body mass index for peripartum women who subsequently developed 
breast cancer compared with women who remained cancer-free.
Subjects.
The study population is a subset of the Child Health and Development Studies (CHDS) 
pregnancy cohort that was the basis of our previous prospective study on postpartum serum 
DDT and subsequent breast cancer.5 The sample size for the current study was based on the 
study sample for our previous report in order to further discover possible mechanisms that 
explained our finding that postpartum serum DDT predicted risk of breast cancer. Briefly, 
pregnant women entered the study at an average age of 26 years, during pregnancies 
occurring from 1959-1966 (with deliveries extending through 1967) and have been followed 
for place of residence, vital status, and cancer incidence since that time.5 Archived 
pregnancy serum samples were collected from 1959-1967 during peak DDT exposure in the 
U.S., and were assayed for p,p’-DDT, p,p’-DDE and o,p’-DDT in non-fasting early 
postpartum samples drawn between 1-3 days after delivery. The laboratory that measured 
serum DDT compounds was blind to case status. Cases and their matched control were 
assayed in the same batch with order randomized within batch and case-control strata were 
randomized across batches. Details are given in our previous report.5 For the present study 
we report on 133 women diagnosed with breast cancer before age 50 as of 1998. Cases were 
diagnosed an average of 17 years after entry into the study. One control subject, who 
remained free of breast cancer as of the age of the case, was matched to each case on year of 
birth. This study population is the basis of our previous report on postpartum DDT and 
subsequent breast cancer in the CHDS where details are given.5
Statistical Methods
Height measured in early pregnancy and weight measured closest to the time the blood 
sample was drawn was used to calculate maternal body mass index (weight in kg/ height in 
m2) (BMI). In order to address the role of blood lipids in analyses we compared and report 
results of models for two alternative approaches: 1) DDT outcomes based on wet weight 
Cohn et al. Page 3
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2020 February 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(ng/mL) adjusted for serum triglycerides and cholesterol within the model and 2) DDT 
outcomes standardized for serum cholesterol and triglycerides (ug/g lipid)21, which we refer 
to as lipid standardized DDTs throughout the manuscript. This strategy was based on a 
report by Schisterman et al. which demonstrated reduced bias of estimates over several 
causal scenarios using adjustment for lipids within the model.22 However, we also provide 
results for lipid standardized DDTs for the purposes of comparison with other reports 
prevalent in the literature.22 We estimated the linear association of BMI with natural log-
transformed (ln) p,p’-DDE, and ln p,p’-DDT for cases compared to controls, using Proc 
Mixed in SAS 9.3 to account for matching. The model contained an indicator variable for 
case status (yes vs. no), BMI, and a product term between case status and BMI to test 
whether the association of BMI with serum DDT compounds differed for women who 
subsequently developed breast cancer compared to women who did not. Models were 
adjusted for African American race/ethnicity (yes versus no), age, and number of previous 
births (parity). Models were based on 129 controls and 130 cases after excluding 2 controls 
and three cases due to missing data on BMI and 2 controls with insufficient serum for lipid 
assays. We tested equality of variance using the Brown-Forsythe test which was not 
significant for case control comparisons of p,p’-DDE or p,p’-DDT. p,p’-DDT and p,p’-DDE 
distributions were highly skewed. Natural log transformation did not result in perfect 
normality, but was superior to square and cube root transformations. We conducted 
additional sensitivity analyses. First we conducted an additional non-parametric analysis by 
calculating partial Spearman correlation coefficients (Proc Corr in SAS 9.3) to determine 
whether results would be consistent with regression results. We examined outliers using box 
plots to identify observations that were > 1.5 x the interquartile range for the DDT 
compounds to investigate whether these outliers showed patterns suggesting laboratory error. 
We excluded case-control strata from Proc Mixed regression models where Cooks Distance 
exceeded 0.03 (4/130 strata) and compared estimates of BMI slopes with those based on the 
full sample to determine the impact of influential observations on regression models. 
Subjects voluntarily participated in the CHDS, giving oral informed consent. This study was 
approved by the Institutional Review Board for the Protection of Human Subjects at the 
Public Health Institute. Code Availability: Computer code used in this study can be obtained 
from the authors. Analyses were completed using Statistical Analysis System (SAS) 9.3. All 
statistical tests were two sided.
RESULTS
Blood samples for this study were collected at a time when DDT use was active and 
widespread in the U.S. Therefore all CHDS women were exposed and DDTs were detected 
in 100% of serum samples. Characteristics of cases and controls are shown in Table 1. 
Figure 1 presents correlations of BMI with lipid standardized DDT compounds for breast 
cancer cases an average of 17 years prior to diagnosis compared to controls. We observed an 
inverse correlation between BMI and early postpartum serum p,p’-DDE or serum p,p’-DDT 
among women who remained free of breast cancer before age 50 (Figure 1). In contrast, we 
did not observe an inverse correlation between BMI and early postpartum DDTs among 
women who subsequently developed breast cancer before age 50 (Figure 1). The patterns 
shown in Figure 1 were also observed for DDTs measured as wet weight concentrations 
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unadjusted for serum lipids (Supplemental Figure A). After adjustment for parity, race, and 
age, the case-control differences in BMI correlations with p,p’-DDE and p,p’-DDT 
(interactions) were statistically significant in regression models (Table 2). The inverse 
correlation of BMI with DDT compounds was statistically significant for controls (Table 2). 
In contrast, there was no evidence of a statistically significant BMI correlation with DDT 
compounds for cases either before (Figure 1 and Supplemental Figure A) or after adjustment 
for age, race, and parity (Table 2). These findings are consistent with results from Spearman 
partial correlation analysis which does not require normal distribution of the dependent 
variable (Table 3). Significant negative Spearman partial correlations of BMI with DDT 
compounds were observed for controls with no significant correlations observed among 
cases (Table 3). Examination of outliers (> 1.5 x interquartile range) revealed that most 
outliers were on the lower end of the DDT and DDE distributions for controls. These 
outliers were women with high BMIs, an observation consistent with the hypothesis that 
BMI would be inversely correlated with DDTs.. The outliers did not cluster by sample batch 
and did not occur within case-control pairs which were analyzed in the same batch. We had 
no basis for excluding these outliers as bad data points. When we used Cooks Distance > 
0.03 to exclude influential observations from regression analyses reported in Table 2, 
whether for lipid standardized or wet weight DDT models, we still observed statistically 
significant interactions of BMI by case status, significant inverse BMI slopes for controls, 
and no significant association of BMI with DDT compounds among cases (for example see 
Supplemental Table A). When we excluded these outliers from graphs shown in Figure 1, 
the graphs remain consistent with results of multivariate models (see Supplemental Figure 
B). Thus we found little evidence that outliers drove study observations and no evidence to 
warrant excluding them.
DISCUSSION
It is well understood that a larger mass of fat will dilute a given amount of lipophilic 
chemical, e.g. DDTs, stored in the fat. As expected,14, 23 in a cross-sectional assessment of 
BMI and DDT during an active DDT exposure period (1960s), we found an inverse 
correlation between BMI and serum DDTs in women who remained cancer-free. We were 
surprised that this correlation was only observed in women who remained cancer-free, but 
was absent in women who subsequently developed breast cancer.
Why would the inverse relationship between serum DDTs and BMI be uncoupled in women 
who subsequently developed breast cancer before age 50? This difference between cases and 
controls is not likely to be due to the presence of occult breast cancer because these subjects 
were an average age of 26 years at the time of blood sampling, and an average of 17 years 
prior to diagnosis. The difference in the BMI – DDTs relationship in cases vs. controls is 
unlikely to be a cohort effect 23 given case and control samples are from the same actively 
exposed cohort and cases and controls are matched on birth year. Further, we found no 
evidence that year of blood draw, which varied only from 1959-1967, explained our findings 
or influenced results.
The absence of an inverse correlation between BMI and serum DDTs in women who went 
on to develop breast cancer before age 50 appears to result from altered metabolism of 
Cohn et al. Page 5
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2020 February 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
DDTs in their fat tissue. A given tissue concentration of DDTs can be altered by a difference 
in exposure, or in the amount of DDTs entering or leaving the tissue. Determining the 
mechanism of this interplay between DDTs, obesity, and later breast cancer may help 
identify biomarkers of breast cancer risk among women exposed to DDTs.
Host factors, particularly excess body fat, could increase the toxicity of lipophilic xenobiotic 
chemicals by enhancing their accumulation and carcinogenic characteristics in body fat 
adjacent to breast epithelium. Siiteri and colleagues previously suggested that the interplay 
of environmental factors and host tissue characteristics could help explain why only some 
women with higher estrogen exposure, such as those with high body fat in the menopause, 
develop estrogen-related cancer while others do not.24
Advantages
The prospective design of this study, with an average follow-up of 17 years, minimizes the 
likelihood of reverse causation. The timing of blood collection was during active DDT 
exposure. It was therefore possible to observe pre-existing differences in BMI-DDT 
correlations during active exposure for women who developed breast cancer before age 50 
compared to women who did not. By examining breast cancers diagnosed before age 50, we 
reduced heterogeneity in the diagnosis group.
Limitations
Our study does not address the majority of breast cancers which occur in women older than 
age 50 and also does not address tumor subtypes. Our study is also limited because it 
considers only DDTs. It is possible that other environmental chemicals or other factors 
correlated with DDTs account for our findings. We could not determine when DDT 
exposure occurred in our study participants. Therefore we do not know whether case-control 
differences reflect long-term storage differences or shorter-term response to recent exposure. 
We measured DDT in non-fasting serum samples and it is possible that the DDT-BMI 
associations we observed do not reflect a steady state. Since this same condition applies to 
both cases and controls we do not expect this limitation to directionally bias our findings, 
though it could contribute to greater variance of our estimates of association. We addressed 
possible case/control differences in fasting state by directly adjusting for serum levels of 
cholesterol and also triglycerides which increase and bind DDT following high fat ingestion, 
at least in rats.25 Our results apply primarily to the DDT-BMI associations proximal to 
pregnancy and the early postpartum which might not reflect equilibrium or the relationship 
of BMI and DDTs at other points in the life-course. However the pregnancy and the 
postpartum windows are considered to be critical windows of susceptibility for breast 
cancer.26 This study did not identify levels of DDTs in adipose tissue directly. Perhaps 
animal studies can make additional contributions to measure DDTs in both serum and 
adipose to better evaluate DDT-related risk for breast cancer. This would be an important 
contribution as birth cohorts who were DDT-exposed are now at the age of breast cancer risk 
and might benefit.
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CONCLUSIONS
Since many potential environmental chemicals are nearly ubiquitous exposures, research 
strategies that characterize differential response may eventually identify susceptible 
individuals, mechanisms and also prevention strategies. There may be a number of 
opportunities to provide mechanistic clues by querying response to exposure based on other 
plausible biological mechanisms. Adipose may be one of many modifiers of exposure 
effects. The role of adipose in risk modification appears to vary early, prior to diagnosis, in 
susceptible women.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Correlation of body mass index with lipid standardized serum DDTs an average of 17 years 
before diagnosis with breast cancer (cases) compared to women who remained cancer-free 
(controls). Regression lines shown are unadjusted for any other covariables. Panel A: p,p’ 
DDE. Panel B: p,p’-DDT.
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Table 2.
Association of BMI with serum DDTs according to subsequent breast cancer diagnosis an average of 17 years 
later
A. Models using wet weight concentrations of DDTs as outcomes and also adjusted for triglycerides and cholesterol within the model
Outcome
Estimated changea
in ng/mL per kg/m2 (95%CI) pinteraction b
ln p,p' DDT (ng/mL)
Controls
−0.04* (−0.07,−0.01)
Cases 0.01 (−0.02, 0.03)
ln p,p'-DDE (ng/mL) 0.01
Controls
−0.06** (−0.09,−0.04)
Cases −0.01 (−0.03, 0.02)
0.004
B. Models using lipid standardized DDTs as outcomes
Outcome
Estimated changea
in ug/g lipid per kg/m2 (95%CI) pinteraction b
ln p,p' DDT (ug/g lipid)
Controls
−0.04* (−0.07,−0.01)
Cases 0.00 (−0.02, 0.03)
ln p,p'-DDE (ug/g lipid) 0.03
Controls
−0.06** (−0.09,−0.04)
Cases −0.01 (−0.04, 0.02)
0.04
Abbreviations:BMI, Body Mass Index(kg/m2); ln, natural log; ug, microgram; g, gram; ng, nanogram; mL, mililiter
a
Estimated Body Mass Index (BMI) slopes significantly different from zero are shown in bold. Slopes were estimated by linear regression in a 
model containing a dichotomous variable for breast cancer diagnosed as of 1998, body mass index (BMI) nearest to DDT sampling, a product term 
between case status and BMI, and adjusted for age, race and parity. Models based on DDT wet weight concentrations as outcomes were 
additionally adjusted for triglycerides and cholesterol. Serum samples were collected between 1959 and 1967, an average of 17 years prior to 
diagnosis for breast cancer cases. Cases were diagnosed before age 50 and were matched, retrospectively, to one control exactly on year of birth. 
This analysis included 130 cases (3 cases excluded due to missing data on BMI) and 129 controls (2 controls excluded due to missing data on BMI 
and 2 controls excluded due to insufficient serum for lipid assays).
bpinteraction is the significance probability for difference in BMI slope for breast cancer cases compared to controls.
*p≤0.01
**p<0.0001
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Table 3.
Spearman partial correlation coefficients for BMI with DDT compounds
Controls (N=129 Cases (N=130)
ln p,p’-DDE (ng/mL)
−0.3a** 0.04a
ln p,p’- DDT (ng/mL)
−0.2a* 0.14a
ln p,p’-DDE (ug/g lipid)
−0.3b*** −0.02b
ln p,p’- DDT (ug/g lipid)
−0.2b* 0.11b
aAdjusted for age, race, parity, triglycerides and cholesterol
bAdjusted for age, race, and parity
*p<0.03
**p<0.0005
***p<0.0001
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